Symbols

AGPU

Axe Compute·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About AGPU

Axe Compute Inc.

Industry

Healthcare Equipment and Supplies

Established Date

04/23/2002

Listing Date

08/26/2015

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.predictive-oncology.com

Security Type

Common stock

Office address

91 43rd Street, Suite 110 Pittsburgh, Pennsylvania 15201

Business

Introduction

Axe Compute Inc., was incorporated in Minnesota on April 23, 2002 and re-incorporated in Delaware in 2013. The company is a knowledge and science driven company that applies artificial intelligence (" AI ") to support the discovery and development of optimal cancer therapies that can ultimately lead to more effective treatments and improve patient outcomes. The company uses AI and a proprietary biobank of 150,000 + tumor samples, classified by tumor type, to provide actionable insights on drug compounds to improve the drug discovery process and increase the probability of success of drug compounds.

Company Financials

EPS

AGPU has released its 2025 Q3 earnings. EPS was reported at -107.25, versus the expected -1.35, missing expectations. The chart below visualizes how AGPU has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

AGPU has released its 2025 Q3 earnings report, with revenue of 3.62K, reflecting a YoY change of -7.40%, and net profit of -77.65M, showing a YoY change of -2409.20%. The Sankey diagram below clearly presents AGPU's revenue sources and cost distribution.